Ibrutinib-Associated Cardiotoxicity: From the Pharmaceutical to the Clinical
Rong Dong,1 Youyou Yan,2 Xiaokang Zeng,3 Nengming Lin,1,2 Biqin Tan1 1Department of Clinical Pharmacy, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 3100...
Saved in:
Main Authors: | Dong R (Author), Yan Y (Author), Zeng X (Author), Lin N (Author), Tan B (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ibrutinib-induced cardiomyopathy
by: Htay Htay Kyi, et al.
Published: (2019) -
Ibrutinib-associated alveolar hemorrhage and spontaneous hemothorax
by: Ismail Tombul, et al.
Published: (2022) -
Ibrutinib-associated pityriasis rosea-like rash
by: Carole Bitar, MD, et al.
Published: (2018) -
Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies
by: Anastasia Stella Perpinia, et al.
Published: (2022) -
Complex dispersions of poloxamers and mesoporous carriers with ibrutinib
by: Igor A. Dain, et al.
Published: (2022)